Quality of Life in Italian Visually Impaired Patients
Launched by AMORE FILIPPO · Feb 21, 2023
Trial Information
Current as of November 06, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the quality of life for visually impaired patients in Italy. Researchers are studying how visual rehabilitation can help people with vision problems and are also testing a questionnaire called the VA LV VFQ. This questionnaire is designed to measure the impact of visual impairment on daily life, and the study aims to see how well it works in the Italian context.
To participate in this trial, individuals must be at least 18 years old and have a visual condition that requires rehabilitation. Participants will need to understand and agree to join the study by signing a consent form. Unfortunately, those under 18 or with certain cognitive difficulties that make it hard to understand the study won’t be eligible. If you decide to join, you can expect to contribute to important research that could help improve the lives of others with similar visual challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects aged 18 years or older, suffering from any visual pathology, who are admitted to specialised visual rehabilitation centres for visual rehabilitation.
- • Ability to understand and sign the informed consent for participation in the study.
- Exclusion Criteria:
- • Less than 18 years of age.
- • Cognitive impairment that, in the opinion of the investigator, limits understanding of the informed consent or the questionnaire.
About Amore Filippo
Amore Filippo is a dedicated clinical trial sponsor committed to advancing medical research and enhancing patient care through innovative therapeutic solutions. With a strong focus on ethical practices and regulatory compliance, Amore Filippo collaborates with leading researchers and healthcare institutions to conduct high-quality clinical trials across various therapeutic areas. Their mission is to deliver safe and effective treatments by fostering a culture of scientific excellence and patient-centered approaches, ultimately contributing to the betterment of global health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Roma, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials